Hands-free technologies might make it easier for motorists to text, talk on the phone, or even use Facebook while they drive, but new findings from the AAA Foundation for Traffic Safety show dangerous mental distractions exist even when drivers keep their hands on the wheel and their eyes on the road. The research found that as mental workload and distractions increase reaction time slows, brain function is compromised, drivers scan the road less and miss visual cues, potentially resulting in drivers not seeing items right in front of them including stop signs and pedestrians. This is the most comprehensive study of its kind to look at the mental distraction of drivers and arms AAA with evidence to appeal to the public to not use these voice-to-text features while their vehicle is in motion.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60391-aaa-research-voice-activated-in-car-tech-undermines-driver-attention
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace. ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to maintain, ScienceCloud improves operational excellence in globally networked research, significantly reducing IT cost and effort.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65595-sciencecloud-software-by-accelrys-advances-collaborative-drug-discovery
Just in time for the busiest travel season of the year, State Farm has released its annual research report on distracted driving, with troubling results. Though texting while driving remains a concern on the nation’s highways, people are also webbing while driving with increasing frequency. These behaviors may pose equal or greater concerns in the effort to reduce distracted driving.
The July 2012 survey of nearly 1000 motorists shines a light on a growing safety concern: people accessing the internet while driving. Four years of data show a significant increase in the use of mobile web services while driving.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56793-state-farm-fourth-annual-survey-shows-significant-use-mobile-web-vehicle
Organizations with the strongest leaders have nearly double the revenue growth compared to those with weaker leaders, according to new research from CEB (NYSE: CEB), the leading member-based advisory company. However, most leaders lack the full complement of skills to thrive in today’s rapidly changing work environment. To remedy this, organizations must adjust their approach to leadership and develop leaders who are able to build and enable powerful networks within the organization, creating conditions for employees to work through and with others to increase productivity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59760-ceb-advises-organizations-to-rethink-approach-to-leadership
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced its next-generation mobile strategy for the laboratory―to provide a flexible and secure mobile computing environment that effectively connects scientists, equipment and materials in today’s laboratories where an increasing number and variety of mobile devices, from smart phones to tablet computers, are in use. With over a decade of experience in pioneering paperless, mobile computing and wireless compliance capabilities in regulated laboratories, Accelrys will empower organizations to deploy purpose-built mobile applications in the lab from research to manufacturing, satisfying specific workflow requirements in accordance with Good Manufacturing Practice.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65931-accelrys-capture-drives-next-generation-mobility-in-the-laboratory
Eagle Rare Kentucky Straight Bourbon Whiskey has named Angie Goodwin of Calhoun, Ky., as the winner of the Grand Prize 2014 Rare Life Award. Eagle Rare will donate $40,000 to Goodwin’s charity, Thumbs Up for Lane Goodwin Childhood Cancer Foundation, and host an awards ceremony in Henderson on March 7. Angie and her late son Lane started the foundation to support childhood cancer research through funding and advocacy and to assist families battling childhood cancer by providing education, financial assistance and a volunteer network.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64624-eagle-rare-bourbon-angie-goodwin-grand-prize-2014-rare-life-award
Pain can negatively affect a person’s quality of life and impede recovery from illness or injury. Recent research compiled by the American Massage Therapy Association (AMTA) suggests that massage can be a helpful pain management strategy for manually controlling symptoms in people suffering metastatic cancer and rheumatoid arthritis, among other illnesses, as well as post-cardiac surgery pain.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61665-amta-massage-therapy-for-pain-relief-cancer-arthritis-post-cardiac-surgery
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
The summer season is coming to an end, but that doesn't mean there isn't some time for you to get a little summer sun. If you're planning a last minute road trip, it's important to plan ahead, research restaurants and hotels and make sure to perform the proper maintenance on your car. And, through the end of August, the Super 8 hotel brand is holding an exciting sweepstakes that will help add some miles to any road trip.
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
http://www.getthehormonecure.com Dr.
Sara Gottfried refuses to accept the traditional medical thinking that
feeling cranky, asexual, tapped out, and sleep-deprived is just part of
being female and aging, and that prescription medication will fix all
problems. In The Hormone Cure, she combines natural therapies with
rigorous scientific testing to help women feel fully alive, especially
in the years prior to menopause. Using an informative questionnaire to
identify common symptoms of hormonal imbalance such as insomnia, low
sex drive, lack of energy, moodiness, hot flashes, and more; detailing
causes; and offering solutions in non-judgmental and thoughtful
language, Dr. Gottfried provides a novel plan based on solid scientific
research. She believes you don't find a cure at the bottom of a pill
bottle.
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
